Alzheimerís and Parkinsonís diseases ó the two most common brain diseases ó share some clinical symptoms, and researchers are learning more about what biological characteristics they may share, too.
ďThere are a lot of common pathways that have been implicated in both,Ē says Mark Frasier, PhD, vice president of research programs at The Michael J. Fox Foundation. ďSo there are some common targets that have been explored and are actually candidates for drug development that could be applicable to both.Ē
Scientists are working together to understand more about Alzheimerís and Parkinsonís and develop new therapies.
ďThe more we learn about the brain, its functions and abnormal functions in these disorders, the more we appreciate that there is so much overlap. And so the ability to collaborate and share information, share data is going to be critical to the success of development of new treatments,Ē says Frasier.
Watch our Webinar on Alzheimer's and Parkinson's diseases.
Subscribe†to the MJFF Parkinsonís Podcast Series.
Learn more†about our Webinar series.